Company Comparison
IndieBio vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | IndieBio | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | San Francisco, CA | San Diego |
| Founded | 2014 | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | — | $48M |
| Valuation | — | — |
What They Build
IndieBio
Biotech accelerator and venture capital firm that invests in early-stage life sciences and biotechnology startups.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
IndieBio
AI Therapeutics
No investors listed.
Sector Overlap
Both IndieBio and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
Now in alpha with select funds. 14-day trial available.